Cargando…
Facilitated Visual Interpretation of Scores in Principal Component Analysis by Bioactivity-Labeling of (1)H-NMR Spectra—Metabolomics Investigation and Identification of a New α-Glucosidase Inhibitor in Radix Astragali
Radix Astragali is a component of several traditional medicines used for the treatment of type 2 diabetes in China. Radix Astragali is known to contain isoflavones, which inhibit α-glucosidase in the small intestines, and thus lowers the blood glucose levels. In this study, 21 samples obtained from...
Autores principales: | Liu, Yueqiu, Nyberg, Nils T., Jäger, Anna K., Staerk, Dan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6155417/ https://www.ncbi.nlm.nih.gov/pubmed/28272319 http://dx.doi.org/10.3390/molecules22030411 |
Ejemplares similares
-
Investigation of Chemomarkers of Astragali Radix of Different Ages and Geographical Origin by NMR Profiling
por: Zheng, Lu, et al.
Publicado: (2015) -
A Systematic Review of Phytochemistry, Pharmacology and Pharmacokinetics on Astragali Radix: Implications for Astragali Radix as a Personalized Medicine
por: Guo, Zhenzhen, et al.
Publicado: (2019) -
Evaluation of the Pharmaceutical Properties and Value of Astragali Radix
por: Gong, Amy G. W., et al.
Publicado: (2018) -
Comparison of the Immunoregulatory Function of Different Constituents in Radix Astragali and Radix Hedysari
por: Liu, Jing, et al.
Publicado: (2010) -
Predicting the grades of Astragali radix using mass spectrometry-based metabolomics and machine learning
por: Yu, Xinyue, et al.
Publicado: (2021)